Home
>
National Drug Code (NDC)
>
Atracurium Besylate
Atracurium Besylate - 25021-659-05 - (atracurium besylate)
Drug Information of Atracurium Besylate
| Product NDC: | 25021-659 |
| Proprietary Name: | Atracurium Besylate |
| Non Proprietary Name: | atracurium besylate |
| Active Ingredient(s): | 10 mg/mL & nbsp; atracurium besylate |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atracurium Besylate
| Product NDC: | 25021-659 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091488 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120501 |
Package Information of Atracurium Besylate
| Package NDC: | 25021-659-05 |
| Package Description: | 10 VIAL in 1 CARTON (25021-659-05) > 5 mL in 1 VIAL |
NDC Information of Atracurium Besylate
| NDC Code | 25021-659-05 |
| Proprietary Name | Atracurium Besylate |
| Package Description | 10 VIAL in 1 CARTON (25021-659-05) > 5 mL in 1 VIAL |
| Product NDC | 25021-659 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | atracurium besylate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120501 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | ATRACURIUM BESYLATE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |
